01—Abstract
Summary
Summary of the 10-Q filed July 29, 2026. Cited figures are marked; the original filing is the authoritative source.
Fortive Corporation's second-quarter 2026 Form 10-Q (quarter ended July 3, 2026) reports total sales of $1,096.8 milliona for the three months, up from $1,016.4 million a year earlier, and $2,166.2 million for the six months versus $2,009.5 million.
Gross profit was $695.3 millionb for the quarter and operating profit was $209.9 million, compared with $169.8 million in the prior-year quarter. Net earnings from continuing operations were $157.3 million, or $0.51 diluted EPS, versus $111.6 million, or $0.33, in the comparable period of 2025. The company describes core revenue growth (non-GAAP) of 6.7% for the quarter and 6.1% year-to-date, driven by pricing and volume, with an operating profit margin of 19.1% in the quarter compared with 16.7% a year earlier.
Balance sheet and capital allocation changed meaningfully during the period. Long-term debt rose to $3,509.3 millionc from $2,306.5 million at year-end 2025, following the May 2026 issuance of $600 million 4.75% notes due 2031 and $500 million 5.25% notes due 2036, which funded repayment of the $900 million 3.15% notes due 2026. Fortive repurchased 12.3 million shares for about $700 million year-to-date, and cash and equivalents stood at $374.2 million.
Total stockholders' equity declined to $6,069.4 milliond from $6,461.1 million, largely due to treasury share purchases. In the business, the company completed a bolt-on acquisition in its Advanced Healthcare Solutions segment for approximately $58 million in net cash, and recorded immaterial revenue and operating results from it in the quarter. Management attributes the margin improvement to pricing, volume, productivity initiatives and tariff refunds, while higher interest expense ($35.4 million in the quarter) reflects a higher weighted average interest rate on the debt portfolio.
02—Key points
Key Highlights
- Q2 2026 total sales of $1,096.8 million, up from $1,016.4 million; core revenue growth (non-GAAP) of 6.7% for the quarter and 6.1% year-to-date.
- Operating profit of $209.9 million in the quarter, with operating profit margin of 19.1% versus 16.7% in the comparable 2025 period.
- Net earnings from continuing operations of $157.3 million, or $0.51 diluted EPS, versus $111.6 million, or $0.33, a year earlier.
- Long-term debt increased to $3,509.3 million from $2,306.5 million after issuing $1.1 billion of senior notes in May 2026 and repaying $900 million of 3.15% notes due 2026.
- Share repurchases totaled about $700 million year-to-date (12.3 million shares at an average $57.13), with $66.7 million remaining under the special repurchase program and 17.7 million shares under the general program.
- Acquired a majority interest in an AHS bolt-on business for about $58 million net of cash acquired, with approximately $52 million of goodwill recorded.
- Management reported no material changes to risk factors, and cash and equivalents were $374.2 million at July 3, 2026.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q3 FY2026, Fortive kept $0.14.
- Revenue$1.10B100.0%
- Cost of revenue−$401.5M36.6%
- Gross profit$695.3M63.4%
- Operating costs−$485.4M44.3%
- Operating income$209.9M19.1%
- Interest, other & tax−$52.6M4.8%
- Net income$157.3M14.3%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2026filed July 29, 2026Financial Statements
Q3 FY2026 against Q3 FY2025
| Line item | Q3 FY2026Q3 FY2025 | Change |
|---|---|---|
| Revenue | $1.10B$1.03B | +6.8% |
| Cost of Revenue | $401.50M$377.90M | +6.2% |
| Gross Profit | $695.30M$649.20M | +7.1% |
| R&D Expenses | $67.50M$62.00M | +8.9% |
| SG&A Expenses | $417.90M$427.60M | −2.3% |
| Operating Expenses | -$485.40M-$489.60M | +0.9% |
| Operating Income | $209.90M$159.60M | +31.5% |
| Interest Expense | -$35.40M-$25.40M | −39.4% |
| Net Income | $157.30M$55.00M | +186.0% |
| EPS (Basic) | $0.52$0.17 | +205.9% |
| EPS (Diluted) | $0.51$0.16 | +218.8% |
| Shares Outstanding (Basic) | 304.20M330.80M | −8.0% |
| Shares Outstanding (Diluted) | 307.60M333.40M | −7.7% |
05—Questions
Frequently Asked Questions
How did Fortive's revenue and profitability perform in the second quarter of 2026?
Total sales rose to $1,096.8 million from $1,016.4 million, and operating profit increased to $209.9 million from $169.8 million. Operating profit margin was 19.1% versus 16.7% a year earlier, which the company attributes to pricing, higher volume, FBS productivity initiatives, lower discrete restructuring spending, and tariff refunds.
What drove the increase in Fortive's debt?
In May 2026 Fortive issued $600 million of 4.75% notes due 2031 and $500 million of 5.25% notes due 2036, with net proceeds of about $1.1 billion. The proceeds were used to repay $900 million of 3.15% notes due 2026 and for general corporate purposes. Commercial paper borrowings also rose to $1,076.6 million, and total long-term debt carrying value reached $3,509.3 million.
How much did Fortive return to shareholders in the first half of 2026?
Fortive repurchased 12.3 million shares for approximately $700 million in the six months ended July 3, 2026, and paid $18.4 million in dividends in the first quarter. Dividends declared in the second quarter of $18 million were paid on July 6, 2026.
What were the segment results?
In the quarter, Intelligent Operating Solutions generated sales of $758.2 million and operating profit of $203.5 million, a 26.8% margin. Advanced Healthcare Solutions generated sales of $338.6 million and operating profit of $38.3 million, an 11.3% margin.
What is the status of the IEEPA tariff refunds mentioned in the filing?
Following the Supreme Court ruling invalidating certain IEEPA tariffs, Fortive has submitted refund claims to U.S. Customs and Border Protection and recognizes approved amounts within cost of sales. The filing states that recoverability, timing and amount remain uncertain, and tariff refunds contributed to margin improvement in the quarter.
06—Continue